AmericaFirst Quantitative Strategies Fund Class A (AFIAX)

6.16
Net Asset Value
-0.48%
1 Day
-0.48%
Year-to-Date
Overall Morningstar Rating
Tactical allocation
Style or Category
4
Sales Expenses
1.82%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to achieve long-term capital appreciation and to achieve positive returns through all market cycles. The fund intends to achieve its investment objective by investing, under normal circumstances, in individual equity and fixed income securities. It will invest in equity securities regardless of market capitalization. The fund may invest in fixed income securities regardless of maturity or credit rating (including lower-rated securities commonly known as "junk bonds" or "high yield bonds").

Performance

1 month+1.64% 3 years+10.20%
3 months+0.12% 5 years+10.12%
1 year-1.33% Since inception+0.82%
Data through --

Peer Comparisonvs. Tactical allocation

 AFIAXCategory
Performance 5-yr return+10.12%+6.18%
Expense ratio1.82%1.65%
Risk 5 year sharpe ratio0.940.81
Net assets$77.7M$931.1M
Average market cap$10.7B$26.8B
Average P/E13.618.5
Portfolio turnover----

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAmericaFirst Funds
Fund manager & tenureRick Gonsalves / 7 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock57.06%
Fixed income33.83%
Cash4.69%
International stock4.42%
Other0.01%
Top 5 Sectors
Portfolio weighting
Healthcare 43.01%
Industrial materials 31.09%
Consumer goods 13.18%
Financial service 12.71%
Business service 0.00%
Top 10 Holdings
Portfolio weighting
CRED iShares Core U.S. Credit Bond ETF6.04%
JNK SPDR® Barclays High Yield Bond ETF5.88%
SJNK SPDR® Barclays Short Term High Yield Bond ETF5.86%
LQD iShares iBoxx $ Investment Grade Corporate Bond ETF5.39%
NS NuStar Energy LP4.69%
OKS ONEOK Partners LP4.26%
BX Blackstone Group4.18%
KKR KKR & Co LP4.09%
CG Carlyle Group LP4.01%
EW Edwards Lifesciences Corp2.61%

To view my watchlist

Not a member yet?

Sign up now for a free account